Factors associated with fetal chromosomal aneuploidy in high-risk pregnant women

Authors

Keywords:

amniocentesis, chromosomal aneuploidy, high-risk pregnancy, prenatal screening, prenatal ultrasonography

Abstract

Introduction: Chromosomal aneuploidy (CA) is one of the leading causes of miscarriage and congenital anomalies, particularly prevalent among high-risk pregnant women.

Objective: To identify the key predictors associated with fetal chromosomal aneuploidy among high-risk pregnant women.

Methods: A prospective study was conducted on 436 high-risk pregnant women at Hanoi Obstetrics and Gynecology Hospital, Vietnam, from April 2021 to December 2024. The participants underwent amniocentesis and karyotyping. Collected risk factors included maternal age, paternal age, history of miscarriage, history of giving birth to children with birth defects, occupational exposure to chemicals, place of residence, and abnormal fetal ultrasound findings. Statistical analysis was performed using both univariate and multivariate logistic regression.

Results: The overall rate of chromosomal aneuploidy was 11.2%, with trisomy 21 being the most common (42.9%). In the univariate analysis, statistically significant risk factors associated with CA included: maternal age ≥ 35 (OR = 2.3; p = 0.007), paternal age ≥ 40 (OR = 2.1; p = 0.033), and abnormal ultrasound findings (OR = 2.2; p = 0.017). In multivariate analysis, only abnormal ultrasound findings remained statistically significant (OR = 2.06; p = 0.022).

Conclusion: Advanced paternal age and abnormal fetal ultrasound findings serve as important predictors for screening fetal chromosomal aneuploidy in high-risk pregnant women.

Downloads

Download data is not yet available.

References

1. Kagan KO, Sonek J, Kozlowski P. Antenatal screening for chromosomal abnormalities. Archives of gynecology obstetrics [Internet]. 2022; 305(4):825-835. DOI: 10.1007/s00404-022-06477-5

2. Melado L, Lawrenz B, Nogueira D, Raberi A, Patel R, Bayram A, et al. Features of chromosomal abnormalities in relation to consanguinity: analysis of 10,556 blastocysts from IVF/ICSI cycles with PGT-A from consanguineous and non-consanguineous couples [Internet]. Scientific reports. 2023; 13(1):8857. DOI: 10.1038/s41598-023-36014-6

3. Chen Y, Lai Y, Xu F, Qin H, Tang Y, Huang X, et al. The application of expanded noninvasive prenatal screening for genome-wide chromosomal abnormalities and genetic counseling [Internet]. Journal of Maternal-Fetal Neonatal Medicine. 2021; 34(16):2710-2716. DOI: 10.1080/14767058.2021.1907333

4. American College of Obstetricians Gynecologists, Society for Maternal-Fetal Medicine. Screening for fetal chromosomal abnormalities: ACOG practice bulletin, number 226 [Internet]. Obstetrics Gynecology. 2020; 136(4):e48-e69. DOI: 10.1097/AOG.0000000000004084

5. Nagaoka SI, Hassold TJ, Hunt PA. Human aneuploidy: mechanisms and new insights into an age-old problem [Internet]. Nature Reviews Genetics. 2012; 13(7):493-504. DOI: 10.1038/nrg3245

6. Elmerdahl FL, Ølgaard SM, Roos L, Petersen OB, Rode L, Hartwig T, et al. Maternal age and the risk of fetal aneuploidy: a nationwide cohort study of more than 500 000 singleton pregnancies in Denmark from 2008 to 2017 [Internet]. Acta Obstetricia et Gynecologica Scandinavica. 2024; 103(2):351-359. DOI: 10.1111/aogs.14713

7. Li J, Yang M, Chen J, Wang D, Sun H, Wang Z, et al. Prenatal exposure to bisphenols, metals, and risk of fetal chromosome numerical abnormalities in high-risk pregnancies: Independent, combined, and interactive effects [Internet]. Journal of Environmental Sciences. 2025. DOI: 10.1016/j.jes.2025.02.043

8. Melo P, Dhillon-Smith R, Islam MA, Devall A, Coomarasamy A. Genetic causes of sporadic and recurrent miscarriage [Internet]. Fertility Sterility. 2023; 120(5):940-944. DOI: 10.1016/j.fertnstert.2023.08.952

9. Kaltsas A, Moustakli E, Zikopoulos A, Georgiou I, Dimitriadis F, Symeonidis EN, et al. Impact of advanced paternal age on fertility and risks of genetic disorders in offspring [Internet]. Genes. 2023; 14(2):486. DOI: 10.3390/genes14020486

10. Zhang R, Chen X, Wang D, Chen X, Wang C, Zhang Y, et al. Prevalence of chromosomal abnormalities identified by copy number variation sequencing in high-risk pregnancies, spontaneous abortions, and suspected genetic disorders [Internet]. Journal of International Medical Research. 2020; 47(3):1169-1178. DOI: 10.1177/0300060518818020

11. Morgan T, Tan CD, Della-Torre M, Jackson-Bey T, DiGiovanni L, Enakpene CA. Determinant of prenatal diagnostic testing among women with increased risk of fetal aneuploidy and genetic disorders [Internet]. American journal of perinatology. 2024; 41(04):470-477. DOI: 10.1055/a-1692-0309

12. Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, et al. First-trimester or second-trimester screening, or both, for Down's syndrome [Internet]. New England Journal of Medicine. 2005; 353(19):2001-2011. DOI: 10.1056/NEJMoa043693

13. Skakkebæk NE, Lindahl-Jacobsen R, Levine H, Anna-Maria A, Jørgensen N, Main KM, et al. Environmental factors in declining human fertility [Internet]. Nature Reviews Endocrinology. 2022; 18(3):139-57. DOI: https://doi.org/10.1038/s41574-021-00598-8

14. Li H, Hu J, Wu Q, Qiu J, Zhang L, Zhu J. Chromosomal abnormalities detected by chromosomal microarray analysis and pregnancy outcomes of 4211 fetuses with high-risk prenatal indications [Internet]. Scientific Reports. 2024; 14(1):15920. DOI: 10.1038/s41598-024-67123-5

15. Seaton SE, Rankin J, Cavero‐Carbonell C, Garne E, Gissler M, Loane M, et al. The healthcare needs of children with Down syndrome in the first year of life: an analysis of the EUROlinkCAT data linkage study [Internet]. Paediatric Perinatal Epidemiology. 2025; 2025:1-8. DOI: 10.1111/ppe.13176

16. Zhang Y, Xu H, Zhang W, Liu K. Non-invasive prenatal testing for the detection of trisomy 13, 18, and 21 and sex chromosome aneuploidies in 68,763 cases [Internet]. Frontiers in Genetics. 2022; 13:864076. DOI: 10.3389/fgene.2022.864076

17. Essers R, Lebedev IN, Kurg A, Fonova EA, Stevens SJC, Koeck RM, et al. Prevalence of chromosomal alterations in first-trimester spontaneous pregnancy loss [Internet]. Nature Medicine. 2023; 29(12):3233-3242. DOI: 10.1038/s41591-023-02645-5

18. Dowlut-McElroy T, Davis S, Howell S, Gutmark-Little I, Bamba V, Prakash S, et al. Cell-free DNA screening positive for monosomy X: clinical evaluation and management of suspected maternal or fetal Turner syndrome [Internet]. American journal of obstetrics gynecology. 2022; 227(6):862-870. DOI: 10.1016/j.ajog.2022.07.004

19. Beverley R, Snook ML, Brieño-Enríquez MA. Meiotic cohesin and variants associated with human reproductive aging and disease [Internet]. Frontiers in cell developmental biology. 2021; 9:710033. DOI: 10.3389/fcell.2021.710033

20. Cimadomo D, Fabozzi G, Vaiarelli A, Ubaldi N, Ubaldi FM, Rienzi L. Impact of maternal age on oocyte and embryo competence [Internet]. Frontiers in endocrinology. 2018; 9:327. DOI: 10.3389/fendo.2018.00327

21. Pendina AA, Krapivin MI, Chiryaeva OG, Petrova LI, Pashkova EP, Golubeva AV, et al. Chromosomal Abnormalities in Miscarriages and Maternal Age: New Insights from the Study of 7118 Cases [Internet]. Cells. 2024; 14(1):8. DOI: 10.3390/cells14010008

22. Kong A, Frigge ML, Masson G, Besenbacher S, Sulem P, Magnusson G, et al. Rate of de novo mutations and the importance of father’s age to disease risk [Internet]. Nature. 2012; 488(7412):471-475. DOI: 10.1038/nature11396

23. Socolov D, Socolov R, Gorduza VE, Butureanu T, Stanculescu R, Carauleanu A, et al. Increased nuchal translucency in fetuses with a normal karyotype—diagnosis and management: an observational study [Internet]. Medicine. 2017; 96(29):e7521. DOI: 10.1097/MD.0000000000007521

Downloads

Published

2025-10-14

How to Cite

1.
Dao The A, Ho Sy H, Nguyen Duy B, Dang Tien T. Factors associated with fetal chromosomal aneuploidy in high-risk pregnant women. Rev. cuba. med. mil [Internet]. 2025 Oct. 14 [cited 2025 Oct. 19];54(4):e025076838. Available from: https://revmedmilitar.sld.cu/index.php/mil/article/view/76838